Research and Markets has announced the addition of the "Hemagglutinin 5 (H5) - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the Hemagglutinin 5 (H5) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report provides an overview of key players involved in Hemagglutinin 5 (H5) targeted therapeutics development and features dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Key Topics Covered:

  1. Introduction
  2. Hemagglutinin 5 Overview
  3. Therapeutics Development
  4. Pipeline Products for Hemagglutinin 5 - Overview
  5. Pipeline Products for Hemagglutinin 5 - Comparative Analysis
  6. Hemagglutinin 5 - Therapeutics under Development by Companies
  7. Hemagglutinin 5 - Therapeutics under Investigation by Universities/Institutes
  8. Hemagglutinin 5 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Hemagglutinin 5 - Products under Development by Companies
  13. Hemagglutinin 5 - Products under Investigation by Universities/Institutes
  14. Hemagglutinin 5 - Companies Involved in Therapeutics Development

- Altravax Inc

- Ilyang Pharmaceutical Co Ltd

- Inovio Pharmaceuticals Inc

- NewLink Genetics Corp

- Vaxine Pty Ltd

For more information about this report visit http://www.researchandmarkets.com/research/svq9tm/hemagglutinin_5